Literature DB >> 22043379

Serotype Prevalence and Penicillin-susceptibility of Streptococcus pneumoniae in Oman.

Mubarak M Al-Yaqoubi, Kamal M Elhag.   

Abstract

OBJECTIVES: to determine the prevalent serotypes of Streptococcus pneumoniae and the rate of penicillin-nonsusceptibility among pneumococci in Oman.
METHODS: Pneumococcal isolates encountered during the period of September 2002 to December 2007 in the Royal Hospital were serotyped. Clinical information as well as the penicillin susceptibility reports were retrieved from the hospital information system and medical records.
RESULTS: 120 strains of Streptococcus pneumoniae were isolated of which 85 strains were seroptyped. 20 different serotypes were identified, the most common seroptypes were 9A, 6B, 19F, 14 and 23F. 56% of the strains were not susceptible to pencillin, while 99% of these were susceptible to ceftriaxone. 74.3% and 46.1% of the serotypes are covered by the pneumococcal polysaccharide vaccine and the 7-valent pneumococcal conjugate vaccine respectively.
CONCLUSION: Certain few pneumococcal serotypes such as 9A, 6B and 19F are more prevalent in the Omani community than others. More than half of S. pneumoniae are not susceptible to penicillin while the great majority of the strains are susceptible to ceftriaxone.

Entities:  

Keywords:  Pneumococcal Serotypes Penicillin susceptibility in pneumocci.

Year:  2011        PMID: 22043379      PMCID: PMC3191612          DOI: 10.5001/omj.2011.11

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  15 in total

1.  Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity.

Authors:  Thomas W Hennessy; Rosalyn J Singleton; Lisa R Bulkow; Dana L Bruden; Debby A Hurlburt; Debra Parks; Matthew Moore; Alan J Parkinson; Anne Schuchat; Jay C Butler
Journal:  Vaccine       Date:  2005-09-12       Impact factor: 3.641

2.  Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen.

Authors:  K Sjöström; C Spindler; A Ortqvist; M Kalin; A Sandgren; S Kühlmann-Berenzon; B Henriques-Normark
Journal:  Clin Infect Dis       Date:  2006-01-17       Impact factor: 9.079

3.  The intensive care management, mortality and prognostic indicators in severe community-acquired pneumococcal pneumonia.

Authors:  P D Potgieter; J M Hammond
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

4.  Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates.

Authors:  Ziad A Memish; Hanan H Balkhy; Atef M Shibl; Christopher P Barrozo; Gregory C Gray
Journal:  Int J Antimicrob Agents       Date:  2004-01       Impact factor: 5.283

5.  Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention.

Authors:  Eiman M Mokaddas; Vincent O Rotimi; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

6.  National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-08-31       Impact factor: 17.586

7.  Streptococcus pneumoniae resistance to penicillin and ceftriaxone in a tertiary care center in Saudi Arabia.

Authors:  Ahmed A Al-Aqeeli; Mary L Guy; Suliman A Al-Jumaah
Journal:  Saudi Med J       Date:  2002-04       Impact factor: 1.484

8.  Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Authors:  Allison F Messina; Kathy Katz-Gaynor; Theresa Barton; Naveed Ahmad; Faryal Ghaffar; David Rasko; George H McCracken
Journal:  Pediatr Infect Dis J       Date:  2007-06       Impact factor: 2.129

9.  Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome.

Authors:  Angelique G S C Jansen; Gerwin D Rodenburg; Arie van der Ende; Loek van Alphen; Reinier H Veenhoven; Lodewijk Spanjaard; Elisabeth A M Sanders; Eelko Hak
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

10.  Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited.

Authors:  Pernille Martens; Signe Westring Worm; Bettina Lundgren; Helle Bossen Konradsen; Thomas Benfield
Journal:  BMC Infect Dis       Date:  2004-06-30       Impact factor: 3.090

View more
  1 in total

1.  Streptococcus pneumoniae from Palestinian nasopharyngeal carriers: serotype distribution and antimicrobial resistance.

Authors:  Abedelmajeed Nasereddin; Issa Shtayeh; Asad Ramlawi; Nisreen Salman; Ibrahim Salem; Ziad Abdeen
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.